Identifying predictors of sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide 1 receptor agonist use in hospital among adults with diabetes
Novel diabetes medications were rarely continued or initiated during hospitalization despite a high prevalence of cardiovascular disease, raising the concern for systematic under-utilization after discharge.
Authors
- Bruce A. Perkins (ORCID: https://orcid.org/0000-0002-5885-0046)
- Fahad A. Razak (ORCID: https://orcid.org/0000-0001-9195-7286)
- Amol A. Verma (ORCID: https://orcid.org/0000-0001-6857-931X)
- Michael Colacci (ORCID: https://orcid.org/0000-0003-4898-6684)
- Ashley Raudanskis
- Shohinee Sarma (ORCID: https://orcid.org/0000-0001-6018-6036)
- Magnus T. Jensen (ORCID: https://orcid.org/0000-0002-0544-5215)
- Tor Biering‐Sørensen (ORCID: https://orcid.org/0000-0003-4209-2778)
- Michael Fralick (ORCID: https://orcid.org/0000-0002-2082-2445)
- Katarina Zorcic
Institutions
- St. Michael's Hospital (CA)
- Beth Israel Deaconess Medical Center (US)
- Steno Diabetes Centers (DK)
- University of Toronto (CA)
- Gentofte Hospital (DK)
- Sinai Health System (CA)
Publication Details
- Journal
- Journal of Diabetes and its Complications
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1016/j.jdiacomp.2024.108945
- Citations
- 4
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.43